Internal Reference Number: FOI_8426
Date Request Received: 05/02/2025 00:00:00
Date Request Replied To: 11/03/2025 00:00:00
This response was sent via: By Email
Request Summary: Biologic medicines in gastroenterology
Request Category: Researcher
| Question Number 1: How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilar • Etrasimod • Filgotinib • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Mirikizumab • Ozanimod • Risankizumab • Tofacitinib • Upadacitinib • Ustekinumab - Stelara • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 1: • Adalimumab - Humira 6 • Adalimumab Biosimilar 47 • Etrasimod 0 • Filgotinib 19 • Golimumab <5 • Infliximab - Remicade <5 • Infliximab Biosimilar 128 • Mirikizumab 6 • Ozanimod 0 • Risankizumab 5 • Tofacitinib <5 • Upadacitinib 25 • Ustekinumab - Stelara 6 • Ustekinumab Biosimilar 83 • Vedolizumab 55 | |
| Question Number 2: Could you please provide the numbers of patients treated for Crohn’s Disease in the last 3 months with the following biologic drugs: • Adalimumab - Humira • Adalimumab Biosimilars • Golimumab • Infliximab - Remicade • Infliximab Biosimilar • Risankizumab • Upadacitinib • Ustekinumab - Sterala • Ustekinumab Biosimilar • Vedolizumab | |
| Answer To Question 2: • Adalimumab - Humira 5 • Adalimumab Biosimilars 39 • Golimumab 0 • Infliximab - Remicade 0 • Infliximab Biosimilar 63 • Risankizumab 5 • Upadacitinib 15 • Ustekinumab - Sterala 5 • Ustekinumab Biosimilar 71 • Vedolizumab 25 | |
| To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
